Intelligent whole-blood imaging flow cytometry for simple, rapid, and cost-effective drug-susceptibility testing of leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intelligent whole-blood imaging flow cytometry for simple, rapid, and cost-effective drug-susceptibility testing of leukemia

Published:2019 Issue:16 Volume:19 Page:2688-2698
ISSN:1473-0197
Container-title:Lab on a Chip
language:en
Short-container-title:Lab Chip

Author:

Kobayashi Hirofumi¹²³⁴⁵^ORCID,Lei Cheng¹²³⁴⁶^ORCID,Wu Yi¹²³⁴⁷,Huang Chun-Jung¹²³⁴⁸,Yasumoto Atsushi⁹²⁴,Jona Masahiro⁹²⁴,Li Wenxuan¹⁰¹¹¹²¹³,Wu Yunzhao¹²³⁴,Yalikun Yaxiaer¹⁴¹⁵¹⁶⁴¹⁷,Jiang Yiyue¹²³⁴,Guo Baoshan¹²³⁴,Sun Chia-Wei⁸¹⁸¹⁹²⁰²¹,Tanaka Yo¹⁴¹⁵¹⁶⁴^ORCID,Yamada Makoto²²²³²⁴⁴,Yatomi Yutaka⁹²⁴,Goda Keisuke¹²³⁴⁶

Affiliation:

1. Department of Chemistry

2. University of Tokyo

3. Tokyo 113-0033

4. Japan

5. Chan Zuckerberg Biohub

6. Institute of Industrial Sciences

7. Department of Computer Science

8. Department of Photonics

9. Department of Clinical Laboratory Medicine

10. Computer Science Department

11. Carnegie Mellon University

12. Pittsburgh

13. USA

14. Center for Biosystems Dynamics Research

15. RIKEN

16. Osaka 565-0871

17. Division of Materials Science

18. College of Electrical and Computer Engineering

19. National Chiao Tung University

20. Hsinchu 300

21. ROC

22. Department of Intelligence Science and Technology

23. Kyoto University

24. Kyoto 606-8501

Abstract

The drug susceptibility of leukemia cells in whole blood is evaluated by using extreme-throughput imaging flow cytometry with deep learning.

Funder

Cabinet Office, Government of Japan

Japan Society for the Promotion of Science

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2019/LC/C8LC01370E

Reference50 articles.

1. The rocky road to personalized medicine in acute myeloid leukaemia

2. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

3. Acute promyelocytic leukemia: where did we start, where are we now, and the future

4. How I treat the older patient with acute myeloid leukemia

5. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of artificial intelligence as a modern technology in advanced cancer therapy;Journal of Drug Delivery Science and Technology;2024-09

2. Diagnosis of Serous Effusion with Intelligent Imaging Flow Cytometry;Advanced Sensor Research;2024-05-13

3. Biomarker-based human and animal sperm phenotyping: the good, the bad and the ugly;Biology of Reproduction;2024-04-19

4. Dispersion-free inertial focusing (DIF) for high-yield polydisperse micro-particles filtration and analysis;2024-01-23

5. Dispersion-free inertial focusing (DIF) for high-yield polydisperse micro-particle filtration and analysis;Lab on a Chip;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3